U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended May 31, 2003
| ¨ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For The Transition Period from to
Commission File Number: 0-11868
CARDIODYNAMICS INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
| California (State or other jurisdiction of incorporation or organization) |
95-533362 (IRS Employer Identification No.) | |
| 6175 Nancy Ridge Drive, Suite 300, San Diego, California (Address of principal executive offices) |
92121 (Zip Code) | |
(858) 535-0202
(Registrants telephone number)
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes x No ¨
As of July 10, 2003, 46,200,724 shares of common stock and no shares of preferred stock were outstanding.
CARDIODYNAMICS INTERNATIONAL CORPORATION
FORM 10-Q
-2-
PART I FINANCIAL INFORMATION
| Item 1. Financial | Statements |
CARDIODYNAMICS INTERNATIONAL CORPORATION
Balance Sheets
(Unaudited, in thousands, except share data)
| May 31, 2003 |
November 30, 2002 | |||||
| Assets |
||||||
| Current assets: |
||||||
| Cash and cash equivalents |
$ | 7,179 | $ | 6,879 | ||
| Accounts receivable, net of allowance for doubtful accounts of $2,230 in 2003 and $1,726 in 2002 |
7,946 | 8,349 | ||||
| Inventory, net |
3,494 | 3,474 | ||||
| Current portion of long-term receivables |
2,487 | 2,522 | ||||
| Other current assets |
336 | 222 | ||||
| Total current assets |
21,442 | 21,446 | ||||
| Property and equipment, net |
539 | 414 | ||||
| Long-term receivables and note receivable, net |
1,785 | 1,654 | ||||
| Other assets |
52 | 52 | ||||
| Total assets |
$ | 23,818 | $ | 23,566 | ||
| Liabilities and Shareholders Equity |
||||||
| Current liabilities: |
||||||
| Accounts payable |
$ | 1,111 | $ | 1,528 | ||
| Accrued expenses |
111 | 173 | ||||
| Accrued salaries, wages and benefits |
1,147 | 1,195 | ||||
| Income taxes payable |
48 | | ||||
| Current portion of deferred service revenue |
247 | 285 | ||||
| Current portion of deferred rent |
16 | 16 | ||||
| Reserve for warranty repairs current |
18 | 69 | ||||
| Current portion of capital lease obligations |
16 | 16 | ||||
| Total current liabilities |
2,714 | 3,282 | ||||
| Long-term portion of deferred service revenue |
133 | 166 | ||||
| Long-term portion of deferred rent |
101 | 106 | ||||
| Reserve for warranty repairs long-term |
440 | 264 | ||||
| Long-term obligations under capital leases |
11 | 24 | ||||
| Total long-term liabilities |
685 | 560 | ||||
| Total liabilities |
3,399 | 3,842 | ||||
Continued
-3-
CARDIODYNAMICS INTERNATIONAL CORPORATION
Balance Sheets (Continued)
(Unaudited, in thousands, except share data)
| May 31, 2003 |
November 30, 2002 |
|||||||
| Commitments and contingencies |
$ | | $ | | ||||
| Shareholders equity: |
||||||||
| Preferred stock, 18,000,000 shares authorized, no shares issued or outstanding at May 31, 2003 or November 30, 2002 |
| | ||||||
| Common stock, no par value, 100,000,000 shares authorized, issued and outstanding 46,186,787 at May 31, 2003 and 46,171,584 shares at November 30, 2002 |
49,832 | 49,774 | ||||||
| Accumulated other comprehensive income |
6 | 3 | ||||||
| Accumulated deficit |
(29,419 | ) | (30,053 | ) | ||||
| Total shareholders equity |
20,419 | 19,724 | ||||||
| Total liabilities and shareholders equity |
$ | 23,818 | $ | 23,566 | ||||
See accompanying notes to financial statements.
-4-
CARDIODYNAMICS INTERNATIONAL CORPORATION
Statements of Operations
(Unaudited In thousands, except per share data)
| Three Months Ended May 31, |
Six Months Ended May 31, |
|||||||||||||||
| 2003 |
2002 |
2003 |
2002 |
|||||||||||||
| Net sales |
$ | 7,285 | $ | 5,623 | $ | 13,670 | $ | 9,989 | ||||||||
| Cost of sales |
1,672 | 1,560 | 3,304 | 2,838 | ||||||||||||
| Gross margin |
5,613 | 4,063 | 10,366 | 7,151 | ||||||||||||
| Operating expenses: |
||||||||||||||||
| Research and development |
784 | 611 | 1,520 | 1,253 | ||||||||||||
| Selling and marketing |
3,870 | 3,049 | 7,351 | 5,770 | ||||||||||||
| General and administrative |
479 | 422 | 978 | 861 | ||||||||||||
| Total operating expenses |
5,133 | 4,082 | 9,849 | 7,884 | ||||||||||||
| Income (loss) from operations |
480 | (19 | ) | 517 | (733 | ) | ||||||||||
| Other income (expense): |
||||||||||||||||
| Interest income |
82 | 76 | 175 | 182 | ||||||||||||
| Interest expense |
(5 | ) | (3 | ) | (10 | ) | (6 | ) | ||||||||
| Other, net |
| (6 | ) | | (25 | ) | ||||||||||
| Total other income |
77 | 67 | 165 | 151 | ||||||||||||
| Income (loss) before provision for income taxes |
557 | 48 | 682 | (582 | ) | |||||||||||
| Provision for income taxes |
(39 | ) | (1 | ) | (48 | ) | (1 | ) | ||||||||
| Net income (loss) |
$ | 518 | $ | 47 | $ | 634 | $ | (583 | ) | |||||||
| Net income (loss) per common share, basic and diluted |
$ | .01 | $ | .00 | $ | .01 | $ | (.01 | ) | |||||||
| Weighted-average number of shares used in per share calculation: |
||||||||||||||||
| Basic |
46,187 | 46,114 | 46,184 | 46,024 | ||||||||||||
| Diluted |
47,104 | 47,433 | 47,176 | 46,024 | ||||||||||||
See accompanying notes to financial statements.
-5-
CARDIODYNAMICS INTERNATIONAL CORPORATION
Statements of Cash Flows
(Unaudited In thousands)
| Six Months Ended May 31, |
||||||||
| 2003 |
2002 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income (loss) |
$ | 634 | $ | (583 | ) | |||
| Adjustments to reconcile net income (loss) to net cash provided by (used) in operating activities: |
||||||||
| Depreciation and amortization |
147 | 144 | ||||||
| Provision for obsolete inventory |
15 | 56 | ||||||
| Provision for warranty repairs |
125 | 78 | ||||||
| Provision for (reduction in) demonstration inventory |
8 | (16 | ) | |||||
| Provision for doubtful receivables |
504 | 188 | ||||||
| Provision for doubtful long-term receivables |
13 | 25 | ||||||
| Compensatory stock options granted |
19 | 36 | ||||||
| Other non-cash items |
3 | | ||||||
| Changes in operating assets and liabilities: |
||||||||
| Accounts receivable |
(101 | ) | 371 | |||||
| Inventory |
(43 | ) | (760 | ) | ||||
| Other current assets |
(114 | ) | (240 | ) | ||||
| Long-term receivables and note receivable |
(109 | ) | (24 | ) | ||||
| Accounts payable |
(417 | ) | 112 | |||||
| Accrued expenses |
(62 | ) | (15 | ) | ||||
| Accrued salaries, wages and benefits |
(48 | ) | (82 | ) | ||||
| Income taxes payable |
48 | | ||||||
| Deferred rent |
(5 | ) | | |||||
| Deferred service revenue |
(71 | ) | (10 | ) | ||||
| Net cash provided by (used in) operating activities |
546 | (720 | ) | |||||
| Cash flows from investing activities: |
||||||||
| Purchases of property and equipment |
(272 | ) | (92 | ) | ||||
| Net cash used in investing activities |
(272 | ) | (92 | ) | ||||
Continued
See accompanying notes to financial statements.
-6-
CARDIODYNAMICS INTERNATIONAL CORPORATION
Statements of Cash Flows (Continued)
(Unaudited In thousands)
| Six Months Ended May 31, |
||||||||
| 2003 |
||||||||